At London Bridge Hospital, minimising the risk of healthcare associated infection, including MRSA infection, for each patient is a matter of continuous vigilance, robust infection surveillance systems and ongoing training of staff at all levels in hospital hygiene. Our entire care infection control procedures are supervised and reinforced by our experienced and dedicated Infection Control Nurses and Consultant Medical advisers.
Staphylococcus aureus is an organism commonly found on the skin and in the nose of healthy people. About 30% of us carry this bacterium and the population affected is continually changing. Methicillin resistant Staph aureus (MRSA) is a much less common variant which is resistant to penicillin and cephalosporin antibiotics commonly used to treat sensitive strains. There are many other antibiotics readily available to treat MRSA infection. These organisms may also be transiently present on the skin without causing infection. However, like sensitive Staph aureus, on occasion, these organisms can cause infection and, rarely, blood infection or septicaemia.
This commitment to the highest quality standard has successfully kept the incidence of MRSA infection at very low levels. Almost all of our MRSAs are imported and contained. Secondary spread is very unusual.
Other factors that contribute to our high quality record include:
Patients admitted to London Bridge Hospital, either as a inpatient or as a daycase, are screened for MRSA carriage by taking a swab from the anterior part of the nose (the most common site of staphylococcal carriage, including MRSA) and possibly other key body sites. Should the patient be an MRSA carrier, the procedure may be deferred pending eradication treatment, or if clinically necessary to proceed, will be nursed in strict isolation ("barrier nursing") to reduce the possibility of transmission to healthcare staff or other patients.
© 2007 London Bridge Hospital - A leading Private Hospital in London offering the highest standards of clinical skills and nursing care